focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,240.00
Bid: 4,120.00
Ask: 4,300.00
Change: 80.00 (1.92%)
Spread: 180.00 (4.369%)
Open: 4,120.00
High: 4,240.00
Low: 4,120.00
Prev. Close: 4,160.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Dec 2013 09:08

RNS Number : 7238V
North Atlantic Smlr Co Inv Tst PLC
17 December 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 OCTOBER 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 August 2013 to 31 October 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 October 2013

3 months %

6 months %

1 year 

%

3 years %

5 years %

Diluted NAV*

1,864p 

2.2 

8.4 

25.7

36.7 

84.9 

Mid-market price

1,588p 

6.4 

13.8 

38.0

52.0 

146.2 

Discount to diluted NAV *

14.8% 

Standard & Poor's 500 Composite Index **

1,095.1 

(1.2)

6.5 

25.1

48.4 

81.7 

Russell 2000 **

685.9 

(0.2)

12.4 

35.1

56.4 

105.1 

FTSE All-Share Index

3,585.3 

2.2 

5.8 

18.6

22.1 

64.2 

US Dollar/Sterling exchange rate

1.6066 

(6.0)

(3.2)

0.3

(0.5)

0.6 

 

* Following the conversion of the Loan Notes the performance is shown on the diluted NAV, excluding retained revenue for the period, only. The Board considers that this accurately reflects the underlying performance of the Company

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's holdings in Bionostics and Orthoproducts were sold at a good uplift to the year-end valuation and at a significant premium to cost. As a result, the Company now has cash or near cash balances of circa £80 million.

 

 

Transactions in Own Shares

 

On 26 September 2013, 1,450 Ordinary shares were bought back for cancellation, at a total cost to the Company of £22,000.

 

Since 31 October 2013, a further 13,483 Ordinary shares were bought back for cancellation, in two tranches, at the beginning of December 2013, at a total cost of £208,000.

 

Following these purchases the Company's issued share capital consists of 15,897,501 Ordinary shares.

 

 

 

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2013

Gleeson (MJ) Group

UK Listed

11.5

US Treasury Bills

US Treasury Bills

18.8

Oryx International Growth Fund Limited *

UK Listed

11.5

Trident Private Equity Fund III LLP

UK Unquoted

8.3

Hampton Investment Properties Limited

UK Unquoted

5.2

Bioquell

UK Listed

4.7

Guinness Peat Group **

UK Listed

4.5

Celsis AG

US Unquoted

3.5

AssetCo PLC

UK Listed

2.8

Goals Soccer Centres

UK Listed

2.6

% of total portfolio

73.4

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

20.5

20.5

Treasury Bills

18.8

18.8

Construction & Materials

11.5

11.5

Real Estate

0.2

7.6

0.4

8.2

Support Services

1.0

5.1

6.1

Industrial Engineering

5.1

5.1

Health Care, Equipment & Services

0.2

4.7

4.9

Financial Services

4.5

4.5

Travel & Leisure

3.5

3.5

Media

3.2

3.2

Banks

3.1

3.1

Escrows

1.7

0.4

2.1

Oil & Gas Producers

1.2

0.8

2.0

General Retailers

1.7

1.7

Technology Hardware & Equipment

1.5

1.5

Food Producers

1.3

1.3

Industrial Transportation

1.3

1.3

Business Services

0.7

0.7

 

The financial information for the period ended 31 October 2013 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

17 December 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMMMZLNDGFZG
Date   Source Headline
26th Nov 201511:03 amRNSDirectorate Change
16th Nov 201511:38 amRNSPortfolio Update
10th Nov 20152:26 pmRNSNet Asset Value(s)
5th Nov 201510:48 amRNSTransaction in Own Shares
2nd Nov 201510:38 amRNSHolding(s) in Company
12th Oct 201512:26 pmRNSNet Asset Value(s)
2nd Oct 201512:44 pmRNSHolding(s) in Company
16th Sep 20159:17 amRNSDeath of a Director
15th Sep 20159:54 amRNSNet Asset Value(s)
10th Sep 20156:15 pmRNSHalf Yearly Report
10th Sep 20154:34 pmRNSHolding(s) in Company
12th Aug 201512:46 pmRNSNet Asset Value(s)
17th Jul 20159:39 amRNSNet Asset Value(s)
14th Jul 20159:36 amRNSDirector/PDMR Shareholding
9th Jul 201512:28 pmRNSPortfolio Update
30th Jun 20152:12 pmRNSResult of AGM
11th Jun 20153:31 pmRNSNet Asset Value(s)
26th May 20152:32 pmRNSDoc re. Annual Report
14th May 20156:12 pmRNSFinal Results
13th May 201511:24 amRNSNet Asset Value(s)
29th Apr 201510:11 amRNSHolding(s) in Company
14th Apr 201510:08 amRNSNet Asset Value(s)
2nd Apr 20159:05 amRNSDirector/PDMR Shareholding
1st Apr 20159:21 amRNSDirector/PDMR Shareholding
23rd Mar 201512:43 pmRNSHolding(s) in Company
18th Mar 20153:32 pmRNSNet Asset Value(s)
5th Mar 20159:28 amRNSTransactions in Close Period
2nd Mar 20159:35 amRNSHolding(s) in Company
12th Feb 20155:56 pmRNSNet Asset Value(s)
15th Jan 201510:59 amRNSNet Asset Value(s)
15th Dec 201410:03 amRNSNet Asset Value(s)
10th Dec 20145:13 pmRNSHolding(s) in Company
17th Nov 201410:01 amRNSNet Asset Value(s)
28th Oct 20145:08 pmRNSDirector/PDMR Shareholding
13th Oct 201412:21 pmRNSNet Asset Value(s)
30th Sep 20142:19 pmRNSHalf Yearly Report
24th Sep 201411:09 amRNSHalf Yearly Report
17th Sep 20149:01 amRNSNet Asset Value(s)
10th Sep 20142:49 pmRNSHolding(s) in Company
10th Sep 201410:23 amRNSTransaction in Own Shares
14th Aug 20149:30 amRNSTransaction in Own Shares
13th Aug 20143:44 pmRNSTransactions in a Close Period
11th Aug 201411:16 amRNSNet Asset Value(s)
25th Jul 20142:54 pmRNSTransaction in Own Shares
15th Jul 201411:55 amRNSNet Asset Value(s)
25th Jun 20143:09 pmRNSResult of AGM
18th Jun 20149:24 amRNSInterim Management Statement
10th Jun 201410:38 amRNSNet Asset Value(s)
3rd Jun 20142:44 pmRNSHolding(s) in Company
29th May 20145:52 pmRNSDoc re. Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.